Drugs / Sabin strain inactivated polio vaccine (Vero Cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04386707 | May 2020 | poliomyelitis | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin strain inactivated polio vaccine (Vero Cell) | “The purpose of this study is to evaluate the lot consistency, immunogenicity and safety of three lots of Sabin strain inactivated polio vaccine (Vero Cell) (sIPV) manufactured...” NCT04386707 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04386707 ↗ |
| Modality | Vaccine | “Sabin strain inactivated polio vaccine (Vero Cell) (sIPV)” NCT04386707 ↗ |